CORRECTED-Intellia CEO not involved in Starboard's Bristol-Myers board challenge
March 01, 2019 at 13:55 PM EST
Intellia Therapeutics Inc Chief Executive John Leonard, who U.S. drug maker Bristol-Myers Squibb Co said last week was nominated by hedge fund Starboard Value LP to sit on its board, is not affiliated with the effort, an Intellia spokeswoman said on Thursday.